Pharmaceuticals, Free Full-Text

Pharmaceuticals, Free Full-Text

A potential complication of pharmacotherapy for a given patient is the possibility of various side effects of drugs, which are manifested in many ways and constitute iatrogenic causes of diseases. Among the systemic side effects of drugs, there are also those involving the urinary tract, although these are less reported in the literature. The use of numerous drugs—especially of anticholinergics or drugs with anticholinergic potential, opioid analgesics, non-steroidal anti-inflammatory drugs, antidepressants, first-generation antipsychotics (classic neuroleptics) and selected cardiovascular drugs (beta-blockers, thiazides potassium-sparing diuretics, statins), as well as others—may increase the risk of developing urological disorders, such as urinary retention or incontinence, urinary tract infections, urolithiasis, erectile dysfunction in men and retroperitoneal fibrosis. The purpose of this paper is to characterise the abovementioned drug-induced disorders of the lower urinary tract on the basis of a non-systematic literature review.

Pharmaceuticals, Free Full-Text

Pharmacology Cheat Sheet: Generic Drug Stems - Nurseslabs

Pharmaceuticals, Free Full-Text

Pharmaceuticals, Free Full-Text

Pharmaceuticals, Free Full-Text

Journal of Pharmacy Practice and Research - Wiley Online Library

Pharmaceuticals, Free Full-Text

International Journal of Clinical Pharmacy

Pharmaceuticals, Free Full-Text

Home Page: American Journal of Pharmaceutical Education

Pharmaceuticals, Free Full-Text

Pharmaceutical, Drug & Medicines Bookshop

Pharmaceuticals, Free Full-Text

Bottle of Lies: The Inside Story of the Generic Drug Boom: Eban, Katherine: Books

Pharmaceuticals, Free Full-Text

Mechanisms and Extent of Enhanced Passive Permeation by Colloidal Drug Particles

Pharmaceuticals, Free Full-Text

Systematic Reviews in Pharmacy

Pharmaceuticals, Free Full-Text

Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis

Pharmaceuticals, Free Full-Text

Natural products in drug discovery: advances and opportunities

Pharmaceuticals, Free Full-Text

Rhythm Pharmaceuticals Full Year 2022 Earnings: US$3.48 loss per share (vs US$1.40 loss in FY 2021)